You’ve probably gotten at least 10 emails from HRL recently and you’ve probably opened one of them, at most. Fret not — The Chronicle read all the emails, so you don’t have to.

I spent three weeks testing no-code AI app builders after watching demos that promised perfect apps from single sentences.

This self-hosted diagramming tool takes privacy and control to the next level.

At a time of peak exhaustion with our smartphones and being inundated with study after study that shows how excessive screentimes increase our chances of experiencing insomnia, anxiety, and depression ...

Hytale console commands enable free building, copying, pasting, NPC makeovers, weather resets, time skips, free weapons, and more. So, if you'd like to become overpowered in combat, lessen the ore ...

BUFFALO, N.Y. — Buffalo Mayor Sean Ryan issued his first executive order Monday, prohibiting the use of City of Buffalo personnel and resources for any federal civil immigration enforcement. The city ...

Keeping distracting ads from infiltrating my Android phone has become a necessity rather than a luxury. Blocking them not only saves me time and sanity, but also prevents me from miss-clicking a ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...

Five Senate Republicans voted Thursday to advance a bipartisan resolution on the War Powers Act to block President Trump from using military force against Venezuela, a proposal that if enacted would ...

WASHINGTON — The Senate fired a warning shot at President Donald Trump, voting Thursday to advance a bipartisan resolution to block him from using military force “within or against Venezuela” unless ...

The system, known as the Delete Request and Opt-out Platform, or DROP, has been in the works for years, mandated by a 2023 law known as the Delete Act. Under it and previous laws, data brokers must ...

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved the first at-home brain-stimulation device to treat moderate to severe major ...